BIOLUX P-IV CHINA ( BIOTRONIK )

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 158 participants.

Also called NCT02912715

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 158 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02912715
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02912715. Allocation not applicable; no masking; primary purpose treatment. Start 2016-10 (actual); primary completion 2020-08 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
BIOLUX P-IV CHINA ( BIOTRONIK )
Condition
Peripheral Arterial Disease
Intervention (Device)
Paclitaxel releasing angioplasty balloon
Lead sponsor
Biotronik (Beijing) Medical Device Ltd. (class: industry)

Record details

Record id
cardio:ct-nct02912715
Content hash
46d57e2adce167eb22e8d70a4827e286aae7fd90437a14b77efd441cd4f7b67c